A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 8,210 shares of MEDP stock, worth $2.77 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,210
Previous 5,883 39.55%
Holding current value
$2.77 Million
Previous $2.42 Million 13.01%
% of portfolio
0.03%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $745,989 - $1.06 Million
2,327 Added 39.55%
8,210 $2.74 Million
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $35,712 - $40,736
-96 Reduced 1.61%
5,883 $2.42 Million
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $287,148 - $416,616
-1,008 Reduced 14.43%
5,979 $2.42 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $32,535 - $44,713
-143 Reduced 2.01%
6,987 $2.14 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $233,980 - $281,670
-1,000 Reduced 12.3%
7,130 $1.73 Million
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $1.26 Million - $1.62 Million
-6,751 Reduced 45.37%
8,130 $1.95 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $1.18 Million - $1.62 Million
6,764 Added 83.33%
14,881 $2.8 Million
Q4 2022

Feb 14, 2023

SELL
$153.06 - $226.57 $239,845 - $355,035
-1,567 Reduced 16.18%
8,117 $1.72 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $53,843 - $67,703
371 Added 3.98%
9,684 $1.52 Million
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $218,996 - $282,626
1,682 Added 22.04%
9,313 $1.39 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $36,383 - $56,149
-262 Reduced 3.32%
7,631 $1.25 Million
Q4 2021

Feb 14, 2022

SELL
$182.74 - $227.9 $182 - $227
-1 Reduced 0.01%
7,893 $1.72 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $31,653 - $36,867
-186 Reduced 2.3%
7,894 $1.49 Million
Q2 2021

Aug 16, 2021

SELL
$158.62 - $194.3 $54,089 - $66,256
-341 Reduced 4.05%
8,080 $1.43 Million
Q1 2021

May 17, 2021

SELL
$132.02 - $168.26 $69,442 - $88,504
-526 Reduced 5.88%
8,421 $1.38 Million
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $170,851 - $233,034
-1,562 Reduced 14.86%
8,947 $1.25 Million
Q3 2020

Nov 16, 2020

SELL
$92.95 - $130.61 $845,194 - $1.19 Million
-9,093 Reduced 46.39%
10,509 $1.17 Million
Q2 2020

Aug 13, 2020

SELL
$68.08 - $95.68 $2.38 Million - $3.34 Million
-34,898 Reduced 64.03%
19,602 $1.82 Million
Q1 2020

May 15, 2020

SELL
$61.71 - $101.95 $1.94 Million - $3.2 Million
-31,435 Reduced 36.58%
54,500 $4 Million
Q4 2019

Feb 14, 2020

SELL
$70.08 - $84.64 $1.64 Million - $1.98 Million
-23,424 Reduced 21.42%
85,935 $7.22 Million
Q3 2019

Nov 14, 2019

SELL
$62.38 - $85.89 $1.34 Million - $1.85 Million
-21,533 Reduced 16.45%
109,359 $9.19 Million
Q2 2019

Aug 14, 2019

SELL
$53.64 - $65.42 $303,495 - $370,146
-5,658 Reduced 4.14%
130,892 $8.56 Million
Q1 2019

May 15, 2019

SELL
$49.38 - $70.58 $739,613 - $1.06 Million
-14,978 Reduced 9.88%
136,550 $8.05 Million
Q4 2018

Feb 14, 2019

BUY
$46.97 - $63.98 $7.12 Million - $9.69 Million
151,528 New
151,528 $8.02 Million
Q1 2018

May 15, 2018

SELL
$32.03 - $39.05 $313,541 - $382,260
-9,789 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$32.46 - $38.31 $317,750 - $375,016
9,789
9,789 $355,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.